BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 7583048)

  • 1. Podocyte architecture in puromycin aminonucleoside-treated rats administered tungsten or allopurinol.
    Ricardo SD; Bertram JF; Ryan GB
    Exp Nephrol; 1995; 3(5):270-9. PubMed ID: 7583048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal purine efflux and xanthine oxidase activity during experimental nephrosis in rats: difference between puromycin aminonucleoside and adriamycin nephrosis.
    Ginevri F; Gusmano R; Oleggini R; Acerbo S; Bertelli R; Perfumo F; Cercignani G; Allegrini S; D'Allegri F; Ghiggeri G
    Clin Sci (Lond); 1990 Mar; 78(3):283-93. PubMed ID: 2156648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidants protect podocyte foot processes in puromycin aminonucleoside-treated rats.
    Ricardo SD; Bertram JF; Ryan GB
    J Am Soc Nephrol; 1994 Jun; 4(12):1974-86. PubMed ID: 7919151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for oxygen free radicals in aminonucleoside nephrosis.
    Diamond JR; Bonventre JV; Karnovsky MJ
    Kidney Int; 1986 Feb; 29(2):478-83. PubMed ID: 3702206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allopurinol modulates reactive oxygen species generation and Ca2+ overload in ischemia-reperfused heart and hypoxia-reoxygenated cardiomyocytes.
    Kang SM; Lim S; Song H; Chang W; Lee S; Bae SM; Chung JH; Lee H; Kim HG; Yoon DH; Kim TW; Jang Y; Sung JM; Chung NS; Hwang KC
    Eur J Pharmacol; 2006 Mar; 535(1-3):212-9. PubMed ID: 16516885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.
    Nakayama K; Natori Y; Sato T; Kimura T; Sugiura A; Sato H; Saito T; Ito S; Natori Y
    J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in the charge and size selectivity barrier of the glomerular filter in aminonucleoside nephrosis in rats.
    Olson JL; Rennke HG; Venkatachalam MA
    Lab Invest; 1981 Mar; 44(3):271-9. PubMed ID: 7464051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
    Grond J; Weening JJ; Elema JD
    Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of xanthine oxidase and leukocytes in postburn cardiac dysfunction.
    Horton JW; White DJ
    J Am Coll Surg; 1995 Aug; 181(2):129-37. PubMed ID: 7627385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of the glomerular epithelium in acute aminonucleoside nephrosis. Evidence for formation of occluding junctions and epithelial cell detachment.
    Caulfield JP; Reid JJ; Farquhar MG
    Lab Invest; 1976 Jan; 34(1):43-59. PubMed ID: 1246124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerular epithelial detachment, not reduced charge density, correlates with proteinuria in adriamycin and puromycin nephrosis.
    Whiteside C; Prutis K; Cameron R; Thompson J
    Lab Invest; 1989 Dec; 61(6):650-60. PubMed ID: 2601299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study on the hypouricemic activity and potency in renal xanthine calculus formation of two xanthine oxidase/xanthine dehydrogenase inhibitors: TEI-6720 and allopurinol in rats.
    Horiuchi H; Ota M; Kobayashi M; Kaneko H; Kasahara Y; Nishimura S; Kondo S; Komoriya K
    Res Commun Mol Pathol Pharmacol; 1999; 104(3):307-19. PubMed ID: 10741381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrastructural study on nephrin expression in experimental puromycin aminonucleoside nephrosis.
    Lee YK; Kwon T; Kim DJ; Huh W; Kim YG; Oh HY; Kawachi H
    Nephrol Dial Transplant; 2004 Dec; 19(12):2981-6. PubMed ID: 15385636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The renal clearance of dextran sulfate decreases in puromycin aminonucleoside-induced glomerulosclerosis: a puzzle observation.
    Santos AM; Pomin VH; Stelling MP; GuimarĂ£es MA; Cardoso LR; MourĂ£o PA
    Clin Chim Acta; 2007 Aug; 383(1-2):116-25. PubMed ID: 17599817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of allopurinol, a xanthine oxidase inhibitor, on renal injury in hypercholesterolemia-induced hypertensive rats.
    Minami M; Ishiyama A; Takagi M; Omata M; Atarashi K
    Blood Press; 2005; 14(2):120-5. PubMed ID: 16036490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apocynin but not allopurinol prevents and reverses adrenocorticotropic hormone-induced hypertension in the rat.
    Zhang Y; Chan MM; Andrews MC; Mori TA; Croft KD; McKenzie KU; Schyvens CG; Whitworth JA
    Am J Hypertens; 2005 Jul; 18(7):910-6. PubMed ID: 16053986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive oxygen species in puromycin aminonucleoside nephrosis: in vitro studies.
    Ricardo SD; Bertram JF; Ryan GB
    Kidney Int; 1994 Apr; 45(4):1057-69. PubMed ID: 8007575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allopurinol prevents early alcohol-induced liver injury in rats.
    Kono H; Rusyn I; Bradford BU; Connor HD; Mason RP; Thurman RG
    J Pharmacol Exp Ther; 2000 Apr; 293(1):296-303. PubMed ID: 10734182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of orosomucoid on the glomerular barrier in puromycin aminonucleoside-induced nephrosis.
    Hjalmarsson C; Lidell ME; Haraldsson B
    Nephrol Dial Transplant; 2006 May; 21(5):1223-30. PubMed ID: 16410268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporin reduces proteinuria in rats with aminonucleoside nephrosis.
    Kokui K; Yoshikawa N; Nakamura H; Itoh H
    J Pathol; 1992 Mar; 166(3):297-301. PubMed ID: 1517884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.